Optimization of the generation and propagation of gutless adenoviral vectors

Human Gene Therapy

Volumn 14, Issue 3, 2003, Pages 243-254

  Sakhuja, Kiran ^b   Connelly, Sheila ^a   Reddy, P Seshidhar ^b   Ganesh, Shanthi ^b   Cantaniag, Floro ^b   Pattison, Scott ^b   Limbach, Paullin ^b   Kayda, Dawn B ^b   Kadan, Michael J ^b   Kaleko, Michael ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Advanced Vision Therapies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR;

ARTICLE; BIOREACTOR; CELL LINE; CELL LINE PERC6 CRE; CULTURE MEDIUM; DNA PACKAGING; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE STRUCTURE; GENE TECHNOLOGY; GENETIC CODE; GUTLESS ADENOVIRUS VECTOR; HELPER VIRUS; IMMUNOGENICITY; NONHUMAN; PROCESS OPTIMIZATION; PRODUCT RECOVERY; PRODUCTIVITY; PURIFICATION; SERUM FREE SUSPENSION CULTURE; SIGNAL DETECTION; TOXICITY TESTING; TRANSGENE; VIRAL BACKBONE GENE; VIRAL CONTAMINATION; VIRUS INDUCTION; VIRUS REPLICATION;

ADENOVIRIDAE; GENES, REPORTER; GENETIC VECTORS; HELPER VIRUSES; POLYMERASE CHAIN REACTION;

ADENOVIRIDAE;

EID: 0037429005     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340360535797     Document Type: Article

References (21)

1. BARJOT, C., HARTIGAN-O'CONNOR, D., SALVATORI, G., SCOTT, J.M., and CHAMBERLAIN, J.S. (2002). Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses. J. Gene Med. 4, 480-489.
2. CHESHENKO, N., KROUGLIAK, N., EISENSMITH, R.C., and KROUGLIAK, V.A. (2001). A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther. 8, 846-854.
3. FALLAUX, F.J., BOUT, A., VAN, D.V., VAN DEN WOLLENBERG, I.D.J., HEHIR, K.M., KEEGAN, J., AUGER, C., CRAMER, S.J., VAN ORMONDT, H., VAN DER EB, A.J., VALERIO, D., and HOEBEN, R.C. (1998). New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9, 1909-1917.
4. GORZIGLIA, M.I., KADAN, M.J., YEI, S., LIM, J., LEE, G.M., LUTHRA, R., and TRAPNELL, B.C. (1996). Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70, 173-78.
5. HARDY, S., KITAMURA, M., HARRIS-STANSIL, T., DAI, Y., and PHIPPS, M.L. (1997). Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71, 1842-1849.
6. HARTIGAN-O'CONNOR, D., BARJOT, C., CRAWFORD, R., and CHAMBERLAIN, J.S. (2002). Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selection. Hum. Gene Ther. 13, 519-531.
7. HEARING, P., SAMULSKI, R.J., WISHEART, W.L., and SHENK, T. (1987). Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J. Virol. 61, 2555-2558.
8. HEARING, P., and SHENK, T. (1983). The adenovirus type 5E1A transcriptional control region contains a duplicated enhancer element. Cell 45, 229-236.
9. HILLGENBERG, M., SCHNIEDERS, F., LOSER, P., and STRAUSS, M. (2001). System for efficient helper-dependent minimal adenovirus construction and rescue. Hum. Gene Ther. 12, 643-657.
10. KOCHANEK, S., SCHIEDNER, G., and VOLPERS, C. (2001). High capacity, "gutless" adenoviral vectors. Cur. Opin. Mol. Ther. 3, 454-463.
11. LOCHMULLER, H., JANI, A., HUARD, J., PRESCOTT, S., SIMONEAU, M., MASSIE, B., KARPATI, G., and ACSADI, G. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
12. MITTEREDER, N., MARCH, K.L., and TRAPNELL, B.C. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509.
13. MORRAL, N., O'NEAL, W., RICE, K., LELAND, M., KAPLAN, L., PIEDRA, P.A., ZHOU, H., PARKS, R.J., VELJI, R., AGUILAR-CORDOVA, E., WADSWORTH, W., GRAHAM, F.L., KOCHANEK, S., CAREY, K.D., and BEAUDET, A.L. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U.S.A. 96, 12816-12821.
14. MORRAL, N., PARKS, R.J., ZHOU, H., LANGSTON, C., SCHIEDNER, G., QUINONES, J., GRAHAM, F.L., KOCHANEK, S., and BEAUDET, A.L. (1998). High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity. Hum. Gene Ther. 9, 2709-2716.
15. NG, P., EVELEGH, C., CUMMINGS, D., and GRAHAM, F.L. (2002). Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system. J. Virol. 76, 4181-4189.
16. PARKS, R. CHEN, J.L., ANTON, M., SANKAR, U., RUDNICKI, M.A., and GRAHAM, F.L. (1996). A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U.S.A. 93, 13565-13570.
17. REDDY, P.S., SAKHUJA, K., GANESH, S., YANG, L., KAYDA, D., BRANN, T., PATTISON, S., GOLIGHTLY, D., IDAMAKANTI, N., PINKSTAFF, A., KALOSS, M., BARJOT, C., CHAMBERLAIN, J.S., KALEKO, M., and CONNELLY, S. (2002). Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Mol. Ther. 5, 63-73.
18. SANDIG, V., YOUIL, R., BETT, A.J., FRANLIN, L.L., OSHIMA, M., MALONE, D., WANG, F., METZKER, M.L., SAVINO, R., and CASKEY, C.T. (2000). Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. U.S.A. 97, 1002-1007.
19. SCHIEDNER, G., MORRAL, N., PARKS, R.J., WU, Y., KOOPMANS, S.C., LANGSTON, C., GRAHAM, F.L., BEAUDET, A.L., and KOCHANEK, S. (1998). Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18, 180-183.
20. TOLSTOSHEV, P., MITTEREDER, N., YEI, S., and TRAPNELL, B.C. (1994). Adenovirus vectors for gene therapy. In Cancer Chemotherapy: Challenges for the Future. (Tokyo, Japan) pp. 23-31.
21. ZHU, J., GRACE, M., CASALE, J., CHANG, A.T., MUSCO, M.L., BORDENS, R., GREENBERG, R., SCHAEFER, E., and INDELICATO, S.R. (1999). Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum. Gene Ther. 10, 113-121.